Hada H, Arima T, Togawa K, Okada Y, Morichika S, Nagashima H
Liver. 1986 Aug;6(4):189-98. doi: 10.1111/j.1600-0676.1986.tb01065.x.
In order to clarify the relationship between the integration of hepatitis B virus (HBV) DNA and human hepatocellular carcinoma (HCC), the states of HBV DNA in liver tissues were examined by the Southern blot hybridization procedure. Integration of HBV DNA was found in 12 of 25 HCC cases and 5 of 12 cirrhotic cases. Of these 17 cases, 11 were positive for serum hepatitis B virus surface antigen (HBsAg) and the remaining six were positive for more than one of the serum HBV-related antibodies. In all three cases of chronic hepatitis and 18 controls, integration of HBV DNA could not be detected. Free viral DNA was found in 12 of 15 cases with serum HBsAg. One patient without serum HBsAg also had free viral DNA in the liver. Integration of HBV DNA could be observed in HCC cases positive for serum HBsAg at the highest frequency. However, there was one HCC case from an HBsAg carrier in whom integration of HBV DNA might not have a causal effect on malignant transformation, because integrated HBV DNA could be detected only in a non-tumor region. Since integrated HBV DNA could not be detected in 13 of 25 HCC cases, other etiologic factors than the integration of HBV DNA must also be taken into consideration for HCC.
为了阐明乙型肝炎病毒(HBV)DNA整合与人类肝细胞癌(HCC)之间的关系,采用Southern印迹杂交法检测了肝组织中HBV DNA的状态。在25例HCC病例中有12例、12例肝硬化病例中有5例发现了HBV DNA整合。在这17例病例中,11例血清乙型肝炎病毒表面抗原(HBsAg)呈阳性,其余6例一种以上血清HBV相关抗体呈阳性。在所有3例慢性肝炎病例和18例对照中,均未检测到HBV DNA整合。在15例血清HBsAg阳性的病例中有12例发现了游离病毒DNA。1例无血清HBsAg的患者肝脏中也有游离病毒DNA。血清HBsAg阳性的HCC病例中HBV DNA整合的检出频率最高。然而,有1例来自HBsAg携带者的HCC病例,其中HBV DNA整合可能对恶性转化没有因果关系,因为仅在非肿瘤区域检测到整合的HBV DNA。由于在25例HCC病例中有13例未检测到整合的HBV DNA,因此对于HCC还必须考虑除HBV DNA整合之外的其他病因。